- Home
- IMRX vs DLHC Comparison
IMRX vs DLHC Comparison
Compare IMRX & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- DLHC
- Stock Information
- Founded
- IMRX 2008
- DLHC 1969
- Country
- IMRX United States
- DLHC United States
- Employees
- IMRX N/A
- DLHC N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- DLHC Business Services
- Sector
- IMRX Health Care
- DLHC Consumer Discretionary
- Exchange
- IMRX Nasdaq
- DLHC Nasdaq
- Market Cap
- IMRX 62.7M
- DLHC 75.1M
- IPO Year
- IMRX 2021
- DLHC N/A
- Fundamental
- Price
- IMRX $1.27
- DLHC $3.52
- Analyst Decision
- IMRX Strong Buy
- DLHC
- Analyst Count
- IMRX 2
- DLHC 0
- Target Price
- IMRX $12.50
- DLHC N/A
- AVG Volume (30 Days)
- IMRX 170.4K
- DLHC 98.4K
- Earning Date
- IMRX 05-06-2025
- DLHC 04-30-2025
- Dividend Yield
- IMRX N/A
- DLHC N/A
- EPS Growth
- IMRX N/A
- DLHC 205.25
- EPS
- IMRX N/A
- DLHC 0.44
- Revenue
- IMRX N/A
- DLHC $388,869,000.00
- Revenue This Year
- IMRX N/A
- DLHC N/A
- Revenue Next Year
- IMRX N/A
- DLHC N/A
- P/E Ratio
- IMRX N/A
- DLHC $8.12
- Revenue Growth
- IMRX N/A
- DLHC N/A
- 52 Week Low
- IMRX $1.00
- DLHC $2.72
- 52 Week High
- IMRX $3.83
- DLHC $12.23
- Technical
- Relative Strength Index (RSI)
- IMRX 34.48
- DLHC 41.40
- Support Level
- IMRX $1.23
- DLHC $2.72
- Resistance Level
- IMRX $1.38
- DLHC $3.89
- Average True Range (ATR)
- IMRX 0.11
- DLHC 0.35
- MACD
- IMRX -0.01
- DLHC 0.04
- Stochastic Oscillator
- IMRX 26.42
- DLHC 46.78
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.